| GTO ID | GTC3186 |
| Trial ID | NCT05544526 |
| Disease | Diffuse Midline Glioma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | CAR T Cells to Target GD2 for DMG |
| Year | 2022 |
| Country | United Kingdom |
| Company sponsor | University College, London |
| Other ID(s) | UCL/ 150853 |
| Cohort 1 | |||||||
|
|||||||